Some patients start with a single compound and expand or stack from there
Diadei (IRCCS - Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases Aldo e Cele Dacc)
Market context reflects April 2026
Why Lipo and B12 Are Great Additions to GLP-1s and Other Weight-Loss Programs Weight loss isnt only about the number on the scale, its also about helping your body adapt
Theilgaard Lassen J, Fly Kragh M, Rimestad J, et al
However, as with any medication, rare cases of liver injury cannot be entirely ruled out, and thus, monitoring liver enzymes, especially in patients with pre-existing liver conditions, is prudent